… that could identify differences in tumor biology between racial groups and serve as risk predictors to help alleviate health disparity in disease outcomes. In this study, a research team led by Georgia State University examined whether a biomarker …
Category: Georgia State University
Biomarker Predicts Poor Prognosis in African-Americans with…
… that could identify differences in tumor biology between racial groups and serve as risk predictors to help alleviate health disparity in disease outcomes. In this study, a research team led by Georgia State University examined whether a biomarker …
Concert will benefit local man’s kidney transplant fund.
A concert benefiting the Reed Floyd Kidney Transplant Fund will be held February 25 from 5:30-8:30 pm inside Russell Hall auditorium on the Cochran campus of Middle Georgia State University. Floyd is a Cochran native born with one kidney currently failing.
Georgia State researcher awarded NIH grant to explore pain management therapies for elderly
Dr. Anne Murphy, a biologist of Georgia State University, has received a five-year, $1.8 million grant from the National Institutes of Health , to investigate pain management therapies for people aged 65 or older. As associate professor and associate director of the Neuroscience Institute, Dr. Murphy studies the impact of sex and age on pain and opiate responsiveness as well as the impact of early-life experience on adult responses to pain and stress.
Georgia State University, GeoVax join forces to advance development…
The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections. The Centers for Disease Control and Prevention estimates between 700,000 to 1.4 million people in the United States have chronic Hepatitis B virus infections, with an estimated 20,000 new infections every year.